rs142714816

This variant is located in the ALB gene.

GWAS Catalog Trait Associations (5)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

calcium measurement

Sakaue S et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nature Genetics 53(10):1415-1424 (2021)
Allele G
OR 0.39
p 4.0e-18
N 399,133
Large GWAS
multi-ancestry
Verma A et al. Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science (new York, N.y.) 385(6706):eadj1182 (2024)
Allele G
OR 0.42
p 2.0e-13
N 355,605
Major Consortium StudyLarge GWAS
multi-ancestry
Sinnott-Armstrong N et al. Genetics of 35 blood and urine biomarkers in the UK Biobank. Nature Genetics 53(2):185-194 (2021)
Allele G
OR 0.40
p 7.0e-15
N 325,659
Major Consortium StudyLarge GWAS
multi-ancestry

cysteine measurement

Allele A
OR 1.47
p 3.0e-17
N 14,296
Large GWAS
European

X-12462 measurement

Allele A
OR 1.42
p 4.0e-16
N 14,296
Large GWAS
European

X-14056 measurement

Allele A
OR 1.22
p 2.0e-12
N 14,296
Large GWAS
European

ClinVar annotation

Conflicting Classifications
2 submitters1 publication

Hyperthyroxinemia, familial dysalbuminemic; not provided

View on ClinVar →

About ALB

This gene encodes the most abundant protein in human blood. This protein functions in the regulation of blood plasma colloid osmotic pressure and acts as a carrier protein for a wide range of endogenous molecules including hormones, fatty acids, and metabolites, as well as exogenous drugs. Additionally, this protein exhibits an esterase-like activity with broad substrate specificity. The encoded preproprotein is proteolytically processed to generate the mature protein. A peptide derived from this protein, EPI-X4, is an endogenous inhibitor of the CXCR4 chemokine receptor. [provided by RefSeq, Jul 2016]

View all ALB variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…